艾滋治療新突破! 猴艾滋得到長期控制!

Dr. Anthony Fauci doesn't get too excited about the results of animal studies, and he doesn't make house calls.

對於動物研究的結果，安東尼·弗契博士並不是那麼激動，他也從不上門親訪。

But when a drug already taken by thousands of people for intestinal conditions appeared to control the monkey version of HIV, it got the attention of the director of the National Institutes of Allergy and Infectious Diseases.

但是，當一種被成千上萬人用於腸道環境的藥似乎能夠控制猴類艾滋時，這引起了這名國家過敏和傳染病研究所主任的注意。

Fauci hopped on a plane to Cambridge, Mass., to personally tell Japan's Takeda Pharmaceutical Co's U.S. representatives that their drug may offer a dramatic advance in the fight against AIDS.

弗契乘坐飛往馬薩諸塞州劍橋的飛機，親自告訴日本武田藥業公司的美國代表，他們的藥物可能在抗擊艾滋病方面取得了顯著進步。

Takeda's drug suppressed the virus to undetectable levels in eight monkeys, some for two years.

武田公司的藥物將八個猴子體內的細菌抑制到了不可檢測到的程度，有的甚至長達兩年。

The findings raise hopes for a so-called "functional cure" – a treatment that puts the disease in sustained remission.

這一發現燃起了所謂“功能性治癒”的希望--這種治療方法可以讓疾病得到持續緩解。

"The data was so dramatic," said Fauci, who has made AIDS research his life's work.

將艾滋病研究當作終身事業的弗契說道：“這一數據很激動人心。”

The drug is one of several promising ideas heading into early-stage human trials, all seeking to help patients control the virus that causes AIDS for extended periods without daily antiretroviral therapy (ART).

該藥品是進入早期人體實驗的幾款很有希望的藥物之一，所有這些藥物都試圖在不需要每天進行抗逆轉錄病毒治療（ART）的情況下，幫助患者長期控制艾滋致病病毒。